11th and 12th March 2021

2nd Annual MarketsandMarkets Infectious Disease Diagnostics and Point-Of-Care Testing Virtual Conference (Eastern Standard Time)

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

Point-of-care testing (POCT) is a growing testing. Today, you may see POCT in a hospital with handheld gadgets or small testers in emergency department, extensive care setting, popular clinical wards, and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

In the era of improved diagnostics, our 2nd Annual Virtual Event on Infectious Disease Diagnostics and Point-Of-Care Testing will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.

WHAT TO EXPECT

Key Highlights

Rapid Screening of Infectious Diseases
Microarray technology for diagnostics
Application of Point-Of-Care in disease outbreak
Advancement of technologies in microbiology and its clinical application
Sepsis Detection and its challenges
POCT in critical care and applications in patient monitoring

Why Attend?

Learn about innovative devices and procedures for effective diagnostics
Meet global heads of diagnostics from the industry and Academics
100+ POCT professionals attending
Access to online presentations on-demand post-summit
Case studies presented from leading technology collaborations
Interactive panel discussions

Who Should Attend?

Hospitals/Universities/Labs

Hospitals- Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department

Designation- Senior scientist, scientist, Microbiologist, biologists, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors, POCT coordinators

Pharma/Therapeutics

Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

CONFERENCE AGENDA

Day 1 Thu, 11-Mar-2021
Day 2 Fri, 12-Mar-2021

Online registrations

Welcome note from MarketsandMarkets

Opening Remarks from the Chairman

PATHOGENS DETECTION NEEDS AT POINT OF CARE

Biosensors and lab-on-chip devices for cancer diagnosis and management

09:10 - 09:40 Dr Pedro Estrela, Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath

The pros and cons of point of care testing for COVID-19 virus: virus, antigens and antibodies

09:40 - 10:10 Alan Wu, San Francisco General Hospital, USA, Clinical Chemistry and Toxicology

How the COVID-19 Exposes the Flaws of Current HealthTesting – Hypermobility & Microfluidics for Health 4.0 Tools for new Medicine

10:10 - 10:40 Dr. Ali Tinazli, Chief Commercial Officer , Fluxergy, USA

CLINICAL APPLICATIONS OF POINT-OF-CARE TOWARDS INFECTIOUS DISEASES

Application of Point-Of-Care in disease outbreak

10:40 - 11:10 Nicola Hodges , Point of Care Coordinator , Royal United Hospitals Bath NHS Foundation Trust, UK

Critical needs of reagents and assay kits to fight COVID-19 and SARS-CoV-2 variants

11:10 - 11:40 Dr. Prajwal Paudel , Product Development Scientist , ACROBiosystems,USA

Blockchain-backed participatory research model for rapid customization of an open Lab on a Chip platform towards emerging challenges in point-of-care diagnostics

11:40 - 12:10 Dr. Jens Ducree, Professor of Microsystems in the School of Physical Sciences, , Dublin City University (DCU)

The Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company recently announced has been submitted for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA). The virtual presentation will be webcast to conference attendees and will include a description of the test technology, its workflow processes, and the engineering process involved in its development, as well as a test demonstration.

12:10 - 12:40 Dwight Egan, CEO, Co-diagnostic

Closing remarks from the Chairman

One-to-One networking break| End of Day 1

Online registrations

Welcome note from MarketsandMarkets

Opening Remarks from the Chairman

09:00 - 09:10 Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

POCT IN CRITICAL CARE

Keynote presentation- Training, competency assessment, and maintaining competency of POC users

09:10 - 09:40 Robert H. Christenson, Medical Director - Core Laboratories and Point of Care Testing, University of Maryland Medical Center, USA

COVID-19 – Pandemic. Managing COVID-19 Respiratory Distress Patients Using an Expanded Test Critical Care Analyzer

09:40 - 10:10 Germano Ferrari , Director of Medical and Scientific Affairs(Europe) , NOVA Biomedical,UK

Reducing Errors at Point-Of-Care

10:10 - 10:40 Uchenna Okeahialam, Advanced Biomedical Scientist (POCT), Airedale and Bradford Hospitals Integrated Pathology Solutions, UK

Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale

10:40 - 11:10 Vania Silverio , R&D Microfluidics Scientist , INESC-MN, Portugal

PATIENT MONITORING USING POCT

POCT for covid testing and how it has improved during the pandemic?

11:10 - 11:40 Reshma Kadave, Biomedical Scientist, Imperial College Healthcare NHS Trust, UK

Factors leading to the increase in demand for poct tech and challenges in upholding Quality Standards

11:40 - 12:10 Jyoti Chandok, Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre, Canada

Closing remarks from the Chairman

One-to-One networking break | End of conference

CONFERENCE SPEAKERS

Speakers

Jyoti Chandok

Jyoti Chandok

Assistant-Chief Medical Technologist (Point-of-Care Testing)

McGill University Health Centre

Jyoti Chandok

Assistant-Chief Medical Technologist (Point-of-Care Testing)

McGill University Health Centre

Pedro Estrela

Pedro Estrela

Director, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio)

University of Bath, UK

Pedro Estrela

Director, Centre for Biosensors, Bioelectronics and Biodevices (C3Bio)

University of Bath, UK

Nicola Hodges

Nicola Hodges

Point of Care Coordinator

Royal United Hospitals Bath NHS Foundation Trust, UK

Nicola Hodges

Point of Care Coordinator

Royal United Hospitals Bath NHS Foundation Trust, UK

Hannah Lowe

Hannah Lowe

Clinical Scientist

East Kent Hospitals University NHS Foundation Trust, UK

Hannah Lowe

Clinical Scientist

East Kent Hospitals University NHS Foundation Trust, UK

Vania Silverio

Vania Silverio

R&D Microfluidics Scientist

INESC-MN, Portugal

Vania Silverio

R&D Microfluidics Scientist

INESC-MN, Portugal

Germano Ferrari

Germano Ferrari

Director of Medical and Scientific Affairs(Europe)

NOVA Biomedical,UK

Germano Ferrari

Director of Medical and Scientific Affairs(Europe)

NOVA Biomedical,UK

Dr. Ali Tinazli

Dr. Ali Tinazli

Chief Commercial Officer

Fluxergy, USA

Dr. Ali Tinazli

Chief Commercial Officer

Fluxergy, USA

Robert H. Christenson

Robert H. Christenson

Medical Director - Core Laboratories and Point of Care Testing

University of Maryland Medical Center, USA

Robert H. Christenson

Medical Director - Core Laboratories and Point of Care Testing

University of Maryland Medical Center, USA

SPONSORS

Gold

example-image — Fluxergy

example-image — ACROBiosystems

Sponsors & Exhibitors

example-image — Nova Biomedical

Visiting Partners

example-image — Biokit

example-image — Werfen

example-image — Biocartis

example-image — PerkinElmer

example-image — GenMark Diagnostics

example-image — BioMérieux

Speaking Partner

example-image — Co-Diagnostics

PARTNERS

Media Partners

example-image — PharmaVOICE

example-image — Pharma Journalist

example-image — PharmaTutor

PAST EVENT GALLERY